CytomX Therapeutics (CTMX) Goodwill (2014 - 2026)

CytomX Therapeutics (CTMX) has 13 years of Goodwill data on file, last reported at $949000.0 in Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $949000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $949000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $949000.0, changed 0.0% from the prior year.
• Goodwill steadied at $949000.0 in Q1 2026, from $949000.0 in the prior quarter.
• In the past five years, Goodwill ranged from a high of $949000.0 in Q1 2022 to a low of $949000.0 in Q1 2022.
• A 5-year average of $949000.0 and a median of $949000.0 in 2022 frame the typical range for Goodwill.
• The widest YoY moves for Goodwill: up 0.0% in 2022, down 0.0% in 2022.
• Tracing CTMX's Goodwill over 5 years: stood at $949000.0 in 2022, then changed by 0.0% to $949000.0 in 2023, then changed by 0.0% to $949000.0 in 2024, then changed by 0.0% to $949000.0 in 2025, then changed by 0.0% to $949000.0 in 2026.
• The last three Goodwill figures came in at $949000.0 (Q1 2026), $949000.0 (Q4 2025), and $949000.0 (Q3 2025), per Business Quant data.